Lapatinib acts on gastric cancer through both antiproliferative function and augmentation of trastuzumab-mediated antibody-dependent cellular cytotoxicity-Reference-Cited by-同舟云学术

Lapatinib acts on gastric cancer through both antiproliferative function and augmentation of trastuzumab-mediated antibody-dependent cellular cytotoxicity

Published:2012-11-28 Issue:4 Volume:16 Page:571-580
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Shiraishi Kensuke,Mimura Kousaku,Izawa Shinichiro,Inoue Ayako,Shiba Shugo,Maruyama Takanori,Watanabe Mitsuaki,Kawaguchi Yoshihiko,Inoue Masayuki,Fujii Hideki,Kono Koji

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-012-0219-5.pdf

Reference41 articles.

1. Sawaki A, Ohashi Y, Omuro Y, Satoh T, Hamamoto Y, Boku N, et al. Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study. Gastric Cancer. 2012;15(3):313–22.

2. Abe R, Akiyoshi T. ‘Two-route chemotherapy’ using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer. Oncology. 1990;47:422–6.

3. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg. 1988;208:36–41.

4. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30. doi: 10.1056/NEJMoa010187 .

5. Glehen O, Gilly FN, Cotte E. Hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: the end of skepticism? Ann Surg Oncol. 2011;18:1524–6. doi: 10.1245/s10434-011-1632-4 .

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER-2 positive gastric cancer: Current targeted treatments;International Journal of Biological Macromolecules;2024-08

2. Virtual Screening, Molecular Dynamics Simulation, and Bioactivity Assessment Validate T13074 as a Dual-Target EGFR/c-Met Inhibitor;Current Medicinal Chemistry;2024-06-24

3. CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin;Biomaterials Research;2022-11-26

4. Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first‐line options for HER2‐positive relapsed or metastatic breast cancer;Cancer Innovation;2022-07-14

5. Association between Gastric Cancer Mortality-to-Incidence Ratio and Human Development Index: Evidence from the Global Burden of Disease Study 2016;Archives of Iranian Medicine;2021-12-01